Stay updated on BI456906 Safety & Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.

Latest updates to the BI456906 Safety & Efficacy in NASH Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRemoved the MedlinePlus Genetics topic for Non-alcoholic fatty liver disease, decreasing genetic-topic coverage for this disease.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoChange Detected- Added a government funding notice and operating-status details, and a new MedlinePlus Genetics topic. - Updated revision from v3.1.0 to v3.2.0.SummaryDifference2%

- Check31 days agoChange DetectedRemoved several topics (including Drug Safety-related items and MedlinePlus Genetics content) and an older version tag; added a new version tag v3.1.0. Overall, this is a restructuring/update of topics and versioning with minimal impact on core page content.SummaryDifference0.3%

- Check38 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Non-alcoholic fatty liver disease.SummaryDifference0.2%

- Check45 days agoChange DetectedContent cleanup: removed the topic 'MedlinePlus Genetics related topics: Non-alcoholic fatty liver disease' and the 'Back to Top' link, with the page version updated from v3.0.1 to v3.0.2.SummaryDifference0.2%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%

Stay in the know with updates to BI456906 Safety & Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI456906 Safety & Efficacy in NASH Clinical Trial page.